A Phase I, Single-Centre, Randomised, Open, Three-Way Crossover Study to Evaluate the Effect of Ketoconazole and Verapamil, Respectively, on the Pharmacokinetics of AZD1305 After Repeated Oral Adm [administration] of Ketoconazole and Verapamil and Single Oral Dosing of AZD1305 to Young Healthy Male Volunteers

Trial Profile

A Phase I, Single-Centre, Randomised, Open, Three-Way Crossover Study to Evaluate the Effect of Ketoconazole and Verapamil, Respectively, on the Pharmacokinetics of AZD1305 After Repeated Oral Adm [administration] of Ketoconazole and Verapamil and Single Oral Dosing of AZD1305 to Young Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs AZD 1305 (Primary) ; Ketoconazole; Verapamil
  • Indications Arrhythmias
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 22 Sep 2008 Status changed from recruiting to active, no longer recruiting, as reported in Clinicaltrials.gov record.
    • 25 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top